Investors continue to be optimistic about Medtronic due to strength in its Neurosurgery portfolio. Yet, mounting expenses pose a threat to the company's margins.

Approximately 10% to 20% of total knee arthroplasty (TKA) patients have persistent postoperative pain. Data from a new ...

Analyst reviews BrainsWay's rising share price and recent $20 million private placement, speculating on potential M&A plans ...

Theranica, a prescribed neuromodulation therapeutics company, today announced Medicaid coverage for the Nerivio® REN wearable in four more states: Arizona, New Jersey, Ohio, and Virginia, extending ...

NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq:HSDT) has announced promising preliminary findings from its PoNSTEP study, which evaluates the impact of adherence to the Portable ...

The QPAN® Model, or QEEG-Guided Personalised AI-Based Neuromodulation and Rehabilitation, is an innovative therapeutic ...

Hamad Medical Corporation (HMC) announcedthe launch of two innovative treatment options for patients with treatment resistant ...

Electrochem focuses on non-medical applications for the energy, military, and environmental sectors. The deal follows the ...

2024年9月30日，医疗保健设备公司波士顿科学（BSX）成交额为3.31亿美元，在当日美股中排第250名，成交额较昨日减少19.16%，当日成交量为396.19万。 波士顿科学（BSX）于2024年9月30日涨0.54%，报83.8美元，该股过去5个交易日跌0.24%，整个9月涨2.46%，年初至今涨44.96%，过去52周涨58.71%。

Hamad Medical Corporation (HMC) has launched two innovative options – Esketamine and Transcranial Magnetic Stimulation (TMS) ...

Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI scores from Phase ...

Remedee Labs, a startup based in Paris, France, has received a European approval for its device-based approach to treating ...